X4 Pharmaceuticals (XFOR) Tops Q2 EPS by 46c
Tweet
Share
E-mailGet Alerts XFOR Hot Sheet
Join SI Premium – FREE
X4 Pharmaceuticals (NASDAQ: XFOR) reported Q2 EPS of $0.45, $0.46 better than the analyst estimate of ($0.01). Revenue for the quarter came in at $260 thousand versus the consensus estimate of $15.27 million.
For earnings history and earnings-related data on X4 Pharmaceuticals (XFOR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Regency Centers (REG) Tops Q2 EPS by 2c
- Madrigal Pharma (MDGL) Tops Q2 EPS by 76c
- TFS Financial (TFSL) Tops Q3 EPS by 3c
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
